Medium reagent PlentiPlex™

for cancersliquidassayed

A high sensitivity Assay that is used to identify the presence of the MYD88 L265P mutation, which enables you to distinguish Waldenström macroglobulinemia and lymphoplasmacytic lymphoma from other Lymphoma subtypes. PlentiPlex™ MYD88 Waldenström Lymphoma qPCR Assay utilises PentaBase’s in-house production of custom DNA molecules based on our DNA chemistry, known as Intercalating Nucleic Acid (INA). Therefore, we have created an innovative product that enables further personalised cancer treatment for every patient, contributing to a healthier and safer society. The assay aims to assist with personalised oncological treatment planning, giving precise results within an hour. PlentiPlex™ MYD88 Waldenström Lymphoma qPCR Assay is not intended for diagnosing cancer, but only as an aid to assist the oncologist’s treatment planning. Advantages of PlentiPlex™ MYD88 : Results in less than two hours Reliable and simple readout Enables further personalised cancer treatments Minimal hands-on time